Skip to content

Exploration and clinical application of new core metrics for glucose control in patients with diabetes

Effect of Real-time Continuous Glucose Monitoring System on Diabetes Management in the Hospital

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068933
Enrollment
Unknown
Registered
2023-03-01
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Interventions

Experimental: Real-time Continues Glucose Monitoring sensor system:Real-Time Continuous Glucose Monitoring Telemetry System
Control: Point-of-Care Blood Glucose monitoring:Point-of-Care Blood Glucose Monitoring

Sponsors

Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Males and females = 18 years admitted to Department of Endocrinology and Metabolism. 2. insulin-requiring type 1 or type 2 diabetes patients during hospitalization.

Exclusion criteria

Exclusion criteria: 1. significant hyperglycemia or diabetic ketoacidosis requiring continuous intravenous insulin infusion. 2. Female subjects who are pregnant at time of enrollment into the study. 3. Current users of real-time glucose monitoring sensors or flash-glucose monitoring. 4. Participants were unable to tolerate tape adhesive around sensor placement area, or with medically documented allergy towards the adhesive (glue) of plasters, or with serious skin diseases (e.g. psoriasis vulgaris, bacterial skin diseases) around sensor placement area. 5. Patients expected to require operation, admission to the ICU and MRI procedures during hospitalization. 6. Mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study.

Design outcomes

Primary

MeasureTime frame
Time in range (3.9-10 mmol/L, %) ;

Secondary

MeasureTime frame
Time above range( >10.0 mmol/L, %) ;Time above range( >13.9 mmol/L, %) ;Time below range (<3.9 mmol/L, %);Time below range (<3 mmol/L, %);Mean glucose;glycemia risk index;Coefficient of variation of sensor glucose;Standard deviation of sensor glucose, SDSG;Mean amplitude of glycemic excursions, MAGE;

Countries

China

Contacts

Public ContactJian Zhou

Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

zhoujian@sjtu.edu.cn+86 189 3017 2033

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026